Diagnosis and Treatment of Malaria in Children

Clinical Infectious Diseases

Volumn 37, Issue 10, 2003, Pages 1340-1348

  Stauffer, William ^a,b   Fischer, Philip R ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b REGIONS HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; BENFLUMETOL; BENZODIAZEPINE; BICARBONATE; CHELATING AGENT; CHLOROQUINE; CLINDAMYCIN; CORTICOSTEROID; DEXTRAN; DOXYCYCLINE; FANSIDAR; HALOFANTRINE; HEPARIN; INFUSION FLUID; MANNITOL; MEFLOQUINE; PRIMAQUINE; QUINIDINE DERIVATIVE; QUININE DERIVATIVE;

ACIDOSIS; ANEMIA; ANTIBIOTIC RESISTANCE; BLOOD PRESSURE MONITORING; BLOOD SMEAR; BRAIN MALARIA; CARDIOTOXICITY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; COLLAPSE; COMA; CONFUSION; CYTOKINE RELEASE; DECEREBRATION; DECORTICATION; DISEASE COURSE; DRUG SENSITIVITY; DRUG TOLERABILITY; GASTROINTESTINAL TOXICITY; GAZE PARALYSIS; HEADACHE; HEART ARRHYTHMIA; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; HYPOTENSION; HYPOTHERMIA; HYPOVOLEMIA; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; IRRITABILITY; ISCHEMIA; KIDNEY FAILURE; LABORATORY TEST; LIFE CYCLE; LUNG EDEMA; MALARIA; NEUROTOXICITY; NYSTAGMUS; PAPILLEDEMA; PATIENT MONITORING; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RESPIRATORY DISTRESS; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT DISEASE; RETINA HEMORRHAGE; REVIEW; SEIZURE; SHOCK; SYMPTOMATOLOGY;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; CHILD; CHLOROGUANIDE; CHLOROQUINE; DRUG COMBINATIONS; HUMANS; MALARIA; MALARIA, FALCIPARUM; MEFLOQUINE; NAPHTHOQUINONES; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE;

EID: 0242468542     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379074     Document Type: Review

References (38)

1. World Health Organization (WHO). The global malaria situation: current tools for prevention and control. 55th World Health Assembly. Global Fund to Fight AIDS, Tuberculosis and Malaria. WHO document no. A55/INF.DOC./6. Available at: http://www.who.int/gb/EB_WHA/ PDF/WHA55/ea55id6.pdf. Accessed 7 July 2003.
2. Greenwood B, Mutabingwa T. Malaria in 2002. Nature 2002; 415:670-2.
3. Morrison P, Morrison P. Roll back malaria. Sci Am 2000; 282:104-5.
4. Fischer PA, Bialek R. Prevention of malaria in children. Clin Infect Dis 2002; 34:493-8.
5. Centers for Disease Control and Prevention. Health information for international travel 2003-2004. Atlanta: US Department of Health and Human Services, Public Health Service, 2003.
6. Holtz TH, Kachur SP, MacArthur JR, et al. Malaria surveillance - United States, 1998. MMWR Morb Mortal Wkly Rep 2001; 50(SS-05): 1-20.
7. Stauffer WM, Kamat D. Special challenges in the prevention and treatment of malaria in children. Curr Infect Dis Rep 2003; 5:43-52.
8. Brabin BJ, Ganley Y. Imported malaria in children in the UK. Arch Dis Child 1997; 77:76-81.
9. Minodier P, Lanza-Silhol F, Piarroux R, Gamier JM, Dumon H, Unal D. Le paludisme pediatrique d'importation a Marseille. Arch Pediatr 1999; 6:935-43.
10. Svenson JE, MacLean JD, Gyorkos TW, Keystone J. Imported malaria: clinical presentation and examination of symptomatic travelers. Arch Intern Med 1995; 155:861-8.
11. Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 1998; 27:142-9.
12. Viani RM, Bromberg K. Pediatric imported malaria in New York: delayed diagnosis. Clin Pediatr 1999; 38:333-7.
13. Centers for Disease Control and Prevention. Local transmission of Plasmodium vivax malaria - Virginia 2002. JAMA 2002; 288:2113-4.
14. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344:1973-8.
15. Fischer PR. Malaria and newborns. J Trop Pediatr 2003; 49:132-4.
16. Maroushek SR, Aguilar E. Asymptomatic malaria in Liberian children. Pediatr Res 2002; 51:193A.
17. English MC, Waruiru C, Lightowler C, Murphy SA, Kirigha G, Marsh K. Hyponatraemia and dehydration in severe malaria. Arch Dis Child 1996; 74:201-5.
18. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1):S1-90.
19. Warrell DA. Management of severe malaria. Parassitologia 1999; 41: 287-94.
20. Chandy JC, Idro RI. Parasitic diseases: cerebral malaria in children. Infect Med 2003; 20:53-8.
21. Newton CR, Crawley J, Sowumni A, et al. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child 1997; 76:219-26.
22. Ohrt C, Purnomo, Sutamihardja MA, Tang D, Kain KC. Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis 2002; 186:540-6.
23. Coleman RE, Maneechai N, Rachaphaew N, et al. Comparison of field and expert laboratory microscopy for active surveillance for asymptomatic Plasmodium falciparum and Plasmodium vivax in western Thailand. Am J Trop Med Hyg 2002; 67:141-4.
24. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15:66-78.
25. Craig MH, Bredenkamp BL, Williams CH, et al. Field and laboratory comparative evaluation of ten rapid malaria diagnostic tests. Trans R Soc Trop Med Hyg 2002; 96:258-65.
26. Zalis MG, Ferreira-da-Cruz MF, Balthazar-Guedes HC, et al. Malaria diagnosis: standardization of a polymerase chain reaction for the detection of Plasmodium falciparum parasites in individuals with low-grade parasitemia. Parasitol Res 1996; 82:612-6.
27. Gaye O, Diouf M, Diallo S. A comparison of thick smears, QBC malaria, PCR and PATH falciparum malaria test in Plasmodium falciparum diagnosis. Parasite 1999; 6:273-5.
28. Hanscheid T, Grobusch M. How useful is PCR in the diagnosis of malaria? Trends Parasitol 2002; 18:395-8.
29. Morassin B, Fabre R, Berry A, Magnaval JF. One year's experience with the polymerase chain reaction as a routine method for the diagnosis of imported malaria. Am J Trop Med Hyg 2002; 66:503-8.
30. Schwartz E, Paul F, Pener H, et al. Malaria antibodies and mefloquine levels among United Nations troops in Angola. J Travel Med 2001; 8: 113-6.
31. Gilbert DN, Moellering RC, Sande MA, eds. The Sanford guide to antimicrobial therapy. Hyde Park, VT: Antimicrobial Therapy, 2002.
32. Krogstad DJ. Malaria. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Churchill Livingstone, 1999:736-66.
33. Looareesuwan S, Chulay JD, Canfield CJ, et al. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg 1999; 60:533-41.
34. Borrmann S, Faucher JF, Binder RK, Miller GB, Lell B, Kremsner PG. Atovaquone and proguanil versus amodiaquine in the treatment of uncomplicated Plasmodium falciparum malaria in children weighing ≥5 and <11 kg in Gabon [poster 813]. In: Program and abstracts of the 50th annual meeting of the American Society of Tropical Medicine and Hygiene (Atlanta). Northbrook, IL: American Society of Tropical Medicine and Hygiene, 2001:432.
35. Fivelman QL, Butcher GA, Adagu IS, Warhurst DC, Pasvol G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar J 2002; 1:1.
36. Farnert A, Lindberg J, Gil P, et al. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. BMJ 2003; 326:628-9.
37. White NJ. The treatment of malaria. N Engl J Med 1996; 335:800-6.
38. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995; 332:1399-404.